Emergent BioSolutions Inc.EBSNYSE
Loading
Stockholders Equity Over TimeContracting
Percentile Rank29
3Y CAGR-27.8%
5Y CAGR-18.4%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-27.8%/yr
vs +8.2%/yr prior
5Y CAGR
-18.4%/yr
Recent deceleration
Acceleration
-36.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $522.60M | +8.2% |
| 2024 | $482.80M | -25.6% |
| 2023 | $649.30M | -53.2% |
| 2022 | $1.39B | -13.9% |
| 2021 | $1.61B | +11.4% |
| 2020 | $1.45B | +32.9% |
| 2019 | $1.09B | +7.7% |
| 2018 | $1.01B | +10.8% |
| 2017 | $912.35M | +53.0% |
| 2016 | $596.21M | - |